Azopt (Brinzolamide) - Indications and Dosage

INDICATIONS AND USAGE

AZOPT® (brinzolamide ophthalmic suspension) 1% is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

DOSAGE AND ADMINISTRATION

Shake well before use. The recommended dose is 1 drop of AZOPT® (brinzolamide ophthalmic suspension) 1% in the affected eye(s) three times daily.

AZOPT® (brinzolamide ophthalmic suspension) 1% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure.

If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten minutes apart.

HOW SUPPLIED

AZOPT® (brinzolamide ophthalmic suspension) 1% is supplied in plastic DROP-TAINER® dispensers with a controlled dispensing-tip as follows:

2.5 mL NDC 0065-0275-25     10 mL NDC 0065-0275-10

5 mL NDC 0065-0275-05        15 mL NDC 0065-0275-15

Storage: Store AZOPT® (brinzolamide ophthalmic suspension) 1% at 4-30°C (39-86°F).

Rx Only

U.S. Patent Nos: 5,240,923; 5,378,703; 5,461,081; 6,071,904.

*TRUSOPT is a registered trademark of Merck & Co., Inc.

ALCON LABORATORIES, INC.

Fort Worth, Texas 76134 USA

©2000- 2007 Alcon, Inc.

9002603-0307